Global Stock News

Inclusion of Kintor as a Constituent Stock of HSCI

Article feature image

Inclusion of Kintor as a Constituent Stock of HSCI

SUZHOU, China, Aug. 22, 2021 /PRNewswire/ — Kintor Pharmaceutical Limited (“Kintor Pharma”, HKEX: 9939), a clinical-stage biotechnology company developing innovative small molecule and biological therapeutics, announced today that the company’s stock has…

Click here to view the original article.

Share this article

Scroll to Top